Sera Prognostics, Inc. (SERA) Forward P/S Multiple

Corporate company logo of Sera Prognostics Inc. (SERA)

Overcoming the financial deficit and slow test implementation creates a foundation for growth, which is supported by the forward P/S of Sera Prognostics (SERA). Patent protection of algorithms and clinical trials establish a market barrier, while expansion into the US insurance sector defines the development vector. This chart reflects that the 767.60 metric serves as the target capitalization valuation level relative to expected revenue.

SERA seraprognostics.com: Forward Price to Sales in the range 07/04/2022 - 11/13/2026

Comprehensive metric breakdowns and analytics for seraprognostics.com (SERA)

- market price and analyst price targets:
Price Chart Sera Prognostics|SERA - Analyst Median Target
- market capitalization details:
Market Capitalization Sera Prognostics, Inc.|SERA - Total Enterprise Value
- issuer book value statistics:
Net Assets per Single Share Sera Prognostics|SERA - Accounting Value of Company|Market Capitalization to Book Value Ratio seraprognostics.com|SERA - Company Total Assets
- debt and liquidity data:
Total Debt to Equity Ratio Sera Prognostics|SERA - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Sera Prognostics, Inc.|SERA - Company Aggregate Indebtedness|Debt to Book Capitalization Ratio Sera Prognostics, Inc.|SERA - Company Long-Term Loans and Borrowings|Company Short-Term Debt Sera Prognostics|Quick Ratio seraprognostics.com
- business earnings and investment ratios data:
SERA - Annual Net Income|Expected Profit Sera Prognostics|SERA - Price to Earnings Multiple|Future Price to Earnings Sera Prognostics|SERA - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Sera Prognostics, Inc.|SERA - Operating income before deduction of amortization|Net earnings per share for the last 12 months Sera Prognostics|SERA - Earnings per share for the last four quarters|Quarterly EPS earnings growth seraprognostics.com|SERA - Expected net earnings per share growth this year|Earnings growth forecast for next year Sera Prognostics
- company sales and revenue statistics:
SERA - Company Sales|Company Projected Revenue Sera Prognostics, Inc.|SERA - Price-to-Revenue Coefficient|Price-to-Projected Revenue Ratio Sera Prognostics, Inc.
Fundamental valuation:SERA (Sera Prognostics)
Manufactured products of Sera Prognostics, Inc.

Scaling the PreTRM test through B2B contracts with insurers makes Sera Prognostics (SERA) revenue a key driver of capitalization. By analyzing the forward P/S trend, an investor determines the value of one dollar of projected sales, which allows for an assessment of market expectations regarding the expansion into reproductive diagnostics and the classification of the asset by risk level amid excess liquidity.

Key competitors

Price-to-Projected Revenue Ratio Natera NTRA|Market Cap to Expected Sales Ratio Humacyte Inc (HUMA)